239 related articles for article (PubMed ID: 34980178)
21. Dosimetry study of nasopharyngeal carcinoma based on Halcyon accelerator fixed-field intensity-modulated radiation therapy.
Li K; Li C; Zhu T; Chen J; Cao W; Yin Y; Ma C
J Cancer Res Ther; 2021 Nov; 17(5):1165-1171. PubMed ID: 34850763
[TBL] [Abstract][Full Text] [Related]
22. CBCT-based volumetric and dosimetric variation evaluation of volumetric modulated arc radiotherapy in the treatment of nasopharyngeal cancer patients.
Jin X; Hu W; Shang H; Han C; Yi J; Zhou Y; Xie C
Radiat Oncol; 2013 Dec; 8():279. PubMed ID: 24289312
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric evaluation of automatic and manual plans for early nasopharyngeal carcinoma to radiotherapy.
Zhang Q; Peng Y; Song X; Yu H; Wang L; Zhang S
Med Dosim; 2020 Spring; 45(1):e13-e20. PubMed ID: 31466735
[TBL] [Abstract][Full Text] [Related]
24. A Dosimetric Study of Using Fixed-Jaw Volumetric Modulated Arc Therapy for the Treatment of Nasopharyngeal Carcinoma with Cervical Lymph Node Metastasis.
Zhang WZ; Lu JY; Chen JZ; Zhai TT; Huang BT; Li DR; Chen CZ
PLoS One; 2016; 11(5):e0156675. PubMed ID: 27231871
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of dose-volume histogram prediction for organ-at risk and planning target volume based on machine learning.
Jiao SX; Wang ML; Chen LX; Liu XW
Sci Rep; 2021 Feb; 11(1):3117. PubMed ID: 33542427
[TBL] [Abstract][Full Text] [Related]
26. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.
Lin JF; Yeh DC; Yeh HL; Chang CF; Lin JC
Med Dosim; 2015; 40(3):262-7. PubMed ID: 26116150
[TBL] [Abstract][Full Text] [Related]
27. Beam complexity and monitor unit efficiency comparison in two different volumetric modulated arc therapy delivery systems using automated planning.
Li C; Tao C; Bai T; Li Z; Tong Y; Zhu J; Yin Y; Lu J
BMC Cancer; 2021 Mar; 21(1):261. PubMed ID: 33691654
[TBL] [Abstract][Full Text] [Related]
28. Nasopharyngeal carcinoma radiotherapy with hybrid technique.
Akbas U; Koksal C; Kesen ND; Ozkaya K; Bilge H; Altun M
Med Dosim; 2019 Autumn; 44(3):251-257. PubMed ID: 30366620
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of OAR dose sparing and plan robustness of beam-specific PTV in lung cancer IMRT treatment.
Chang Y; Xiao F; Quan H; Yang Z
Radiat Oncol; 2020 Oct; 15(1):241. PubMed ID: 33069253
[TBL] [Abstract][Full Text] [Related]
30. Dual arc volumetric-modulated arc radiotherapy (VMAT) of nasopharyngeal carcinomas: a simultaneous integrated boost treatment plan comparison with intensity-modulated radiotherapies and single arc VMAT.
Lee TF; Ting HM; Chao PJ; Fang FM
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):196-207. PubMed ID: 21752615
[TBL] [Abstract][Full Text] [Related]
31. Clinical implication in the use of the AAA algorithm versus the AXB in nasopharyngeal carcinomas by comparison of TCP and NTCP values.
Bufacchi A; Caspiani O; Rambaldi G; Marmiroli L; Giovinazzo G; Polsoni M
Radiat Oncol; 2020 Jun; 15(1):150. PubMed ID: 32532351
[TBL] [Abstract][Full Text] [Related]
32. Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT.
Lu SH; Cheng JC; Kuo SH; Lee JJ; Chen LH; Wu JK; Chen YH; Chen WY; Wen SY; Chong FC; Wu CJ; Wang CW
Radiother Oncol; 2012 Sep; 104(3):324-30. PubMed ID: 22236614
[TBL] [Abstract][Full Text] [Related]
33. A plan comparison study between rapid arc and conventional intensity-modulated radiation treatment plans in nasopharyngeal carcinoma patients.
Patidar Y; Kumar HS; Sharma N; Mayilvaganan A
J Cancer Res Ther; 2023; 19(3):543-547. PubMed ID: 37470572
[TBL] [Abstract][Full Text] [Related]
34. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
35. DVH Prediction for VMAT in NPC with GRU-RNN: An Improved Method by Considering Biological Effects.
Zhuang Y; Xie Y; Wang L; Huang S; Chen LX; Wang Y
Biomed Res Int; 2021; 2021():2043830. PubMed ID: 33532489
[TBL] [Abstract][Full Text] [Related]
36. Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complication probability (NTCP).
Boughalia A; Marcie S; Fellah M; Chami S; Mekki F
Br J Radiol; 2015 Jun; 88(1050):20140839. PubMed ID: 25882689
[TBL] [Abstract][Full Text] [Related]
37. Which nasopharyngeal cancer patients need adaptive radiotherapy?
Hu YC; Tsai KW; Lee CC; Peng NJ; Chien JC; Tseng HH; Chen PC; Lin JC; Liu WS
BMC Cancer; 2018 Dec; 18(1):1234. PubMed ID: 30526538
[TBL] [Abstract][Full Text] [Related]
38. Variation in accumulated dose of volumetric-modulated arc therapy for pancreatic cancer due to different beam starting phases.
Sasaki M; Nakamura M; Mukumoto N; Goto Y; Ishihara Y; Nakata M; Sugimoto N; Mizowaki T
J Appl Clin Med Phys; 2019 Oct; 20(10):118-126. PubMed ID: 31539194
[TBL] [Abstract][Full Text] [Related]
39. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.
Hamming-Vrieze O; Depauw N; Craft DL; Chan AW; Rasch CRN; Verheij M; Sonke JJ; Kooy HM
Phys Med Biol; 2019 Apr; 64(9):095001. PubMed ID: 30921775
[TBL] [Abstract][Full Text] [Related]
40. A split-organ delineation approach for dose optimisation for intensity-modulated radiotherapy for advanced T-stage nasopharyngeal carcinoma.
Chau RM; Leung SF; Kam MK; Cheung KY; Kwan WH; Yu KH; Chiu SK; Chan AT
Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):134-41. PubMed ID: 18031999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
